Home > Market > Market Stats >  Aarti Drugs

Company Summary

AARTI DRUGS SUMMARY

Aarti Drugs is trading 0.52% lower at Rs 458.55 as compared to its last closing price. Aarti Drugs has been trading in the price range of 461.5 & 453.0. Aarti Drugs has given -15.53% in this year & 2.08% in the last 5 days.

 

Aarti Drugs has TTM P/E ratio 23.19 as compared to the sector P/E of 27.15. There are 3 analysts who have initiated coverage on Aarti Drugs. There are 0 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.

 

The company posted a net profit of 38.74 Crores in its last quarter.

 

Listed peers of Aarti Drugs include FDC (-0.75%), Hikal (9.63%), Aarti Drugs (-0.52%) etc.

FAQs about Aarti Drugs

Aarti Drugs is trading at 458.55 as on 7 Dec, 2022 3:29:19 PM. This is -0.52% lower as compared to its previous closing price of 460.95
The market capitalization of Aarti Drugs is 4261.92 Cr as on 7 Dec, 2022 3:29:19 PM.
The average broker rating on Aarti Drugs is Hold. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 0 analysts have given a sell rating
  • 2 analysts have given a hold rating
  • 1 analysts have given a buy rating
  • 0 analysts have given a strong buy rating
The 52 wk high for Aarti Drugs is 607.5 whereas the 52 wk low is 378.4
Aarti Drugs can be analyzed on the following key metrics -
  • TTM P/E: 23.19
  • Sector P/E: 27.15
  • Dividend Yield: 0%
  • D/E ratio: -
Aarti Drugs reported a net profit of 205.04 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout